Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

angelman syndrome

POPULAR ARTICLES

Ultragenyx Partners with GeneTx to Advance Treatment for Angelman Syndrome

Ovid Therapeutics Receives Orphan Drug Designation from the European Commission for OV101

Ovid Therapeutics Plans to Move into the Phase 3 Trial Based on End-of-Phase 2 Meeting for OV101

LATEST ARTICLES

Biotech Investing

Ovid Presents Additional Data at AACAP

Ovid Therapeutics Presents Additional Data and Analyses from the Phase 2 STARS Clinical Trial with OV101

Latest News

Altech - $6M Placement to Advance Battery Projects

September Quarter Gold Production Increases by 90%

Successful A$4.5m Two Tranche Placement

Locksley Qualifies for Trading on U.S. OTCQX Market

Successful Completion-Impurity Removal Neutralization Tests

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

RemSense Technologies

REM:AU

Metro Mining

MMI:AU

Blue Jay Gold

Canada One Mining

CONE:CC

Providence Gold Mines

PHD:CC

Valeura Energy

VLE:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES